Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
25. September 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9084
Articles 1 - 20 / 181678
Unsupervised pelvic CBCT-to-CT translation via cross-slice attention for 3D context modeling.
Biomed Phys Eng Express
Chen X, Pang Y, Lian J, Yap PT.
PMID: 42786768 [PubMed - indexed for MEDLINE]
Association of androgen deprivation therapy and acute kidney injury in patients with prostate cancer: a systematic review and meta-analysis of 72,980 patients.
Cancer Chemother Pharmacol
Pires IZ, Fujimura AY Jr, da Silva Gobbo MO, Sudo RYU, Milbradt TL, Filho NM, Carvalhal GF.
PMID: 42786231 [PubMed - indexed for MEDLINE]
Re: Agne Krilaviciute, Nikolaus Becker, Sigrid V. Carlsson, et al. Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-aged Men - Data from the PROBASE Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.06.016.
Eur Urol
Bratt O, Lantz A, Godtman RA.
PMID: 42786067 [PubMed - as supplied by publisher]
Phase 1 Dose-Escalation Study of the Rapid-Clearance Radioligand [(177)Lu]Lu-P17-087 in Metastatic Castration-Resistant Prostate Cancer: Dosimetry, Safety, and Preliminary Efficacy.
J Nucl Med
Zhao R, Li M, Lv J, Zhang J, Zhong H, Fu Y, Liu J, Gu D, Zeng G, Kung HF, Zhu L, Huang J, Wang X.
PMID: 42785946 [PubMed - as supplied by publisher]
Toward precision adjuvant immunotherapy in high-risk clear cell renal cell carcinoma: integrating plasma multiomics with PD-1 blockade.
J Immunother Cancer
Kumar R, Hewa Angappulige D, Song J.
PMID: 42785920 [PubMed - indexed for MEDLINE]
HER1-HER4 expression and co-expression in advanced urothelial carcinoma.
ESMO Open
Coca Membribes S, Berney DM, Beltran L, Nally E, Jackson-Spence F, Szabados B, Mariathasan S, Powles T, Ackerman C.
PMID: 42785914 [PubMed - indexed for MEDLINE]
Renal synovial sarcoma occurring synchronously with renal cell carcinoma.
BMJ Case Rep
Manchanda D, Krishna A, Nayak R, Kini H.
PMID: 42785769 [PubMed - indexed for MEDLINE]
Corrigendum to "Prediction of Distant Metastasis in Renal Cell Carcinoma Using Machine Learning Algorithms: A Multicenter Cohort Study".
Cancer Control
PMID: 42784720 [PubMed - in process]
Precision Diagnostics in Prostate Cancer: Integrating Biomarkers, Imaging, Genomics, and Artificial Intelligence in Contemporary United States Practice.
Med Sci (Basel)
Kardjadj M.
PMID: 42783413 [PubMed - indexed for MEDLINE]
Prognostic Value of a Novel Risk Score Combining Psoas Muscle Density and ALBI Grade in Localized Renal Cell Carcinoma.
Med Sci (Basel)
Makino T, Izumi K, Nakagawa R, Kamijima T, Kadomoto S, Naito R, Iwamoto H, Yaegashi H, Shigehara K, Nohara T, Mizokami A.
PMID: 42783382 [PubMed - indexed for MEDLINE]
Label-Free Refractive-Index-Based Detection of Breast, Leukemia, and Prostate Cancer Cells Using a Tetra-Core PCF SPR Biosensor.
Biosensors (Basel)
Shakya AK, Grigalavi.
PMID: 42783130 [PubMed - indexed for MEDLINE]
Patient Perspectives on Prostate Cancer Prehabilitation: A Qualitative Study Using the Behaviour Change Wheel to Investigate Barriers and Facilitators to Engagement.
Curr Oncol
Harsanyi H, Slot N, Housten AJ, Lee YY, Hyndman ME, Yang L.
PMID: 42782910 [PubMed - indexed for MEDLINE]
Incremental Value of PI-RADS v2.1 for Adverse Pathology at Radical Prostatectomy: A Retrospective 1.5-T MRI Cohort.
Curr Oncol
Kayali Y, Erdemoglu O, Akyol YK, Colak M, Torun A, Bicaklioglu F, Eryildirim B.
PMID: 42782900 [PubMed - indexed for MEDLINE]
From Availability to Access: A Mixed-Methods Study of Digital Prostate Cancer Survivorship Support for Black Men.
Curr Oncol
Okedara O, Ilie G, Brodovsky M, Mason RJ, Rendon R, Kokorovic A, Bailly G, Evans H, Jana K, Nayak JG, Chan E, Flax S, Patil N, Bowes D, Ramiah D, Mutambirwa S, Oberholzer A, Riley L, Cole J, Carruthers W, Taylar S, Rutledge RDH.
PMID: 42782888 [PubMed - indexed for MEDLINE]
Identifying Distinct Quality-of-Life Profiles in Prostate Cancer Patients: A Latent Profile Approach.
Curr Oncol
Cheng L.
PMID: 42782879 [PubMed - indexed for MEDLINE]
Tumour GDF-15 Expression and Clinical Outcomes in Intermediate-Risk Metastatic Clear-Cell Renal Cell Carcinoma Treated with Second-Line Nivolumab.
Curr Oncol
Akdogan O, Ogut B, Sutcuoglu O, Urganci M, Kahya BU, Isik Gonul I, Salimoglu HAB, Ugur Tuzcu T, Yazici O, Ozet A, Ozdemir N.
PMID: 42782878 [PubMed - indexed for MEDLINE]
Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System).
Curr Oncol
Ahmed Z, Sayyid R, Yazdanpanah O, Samaeekia R, Kalebasty AR, Lee DI, Shahait M.
PMID: 42782877 [PubMed - indexed for MEDLINE]
Real-World Outcomes of Second-Line Chemotherapy in Metastatic Urothelial Carcinoma.
Curr Oncol
Ç, Arvas H, Karao, Köylü B, Demir N, Balkaya Aykut G, , Y, Urakç, Bay, Selçukbiricik F, Baydar E, Tazebay BN, Yaz, Bakkal Temi Y, Çabuk D, Uygun K, Kefeli U.
PMID: 42782876 [PubMed - indexed for MEDLINE]
Initial Experience with MR-Guided or CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer.
Curr Oncol
Barcelona MVN, Sanmamed Salgado N, Valencia EG, Berlin A, Glicksman R, Catton C, McPartlin A, Winter JD, Dang J, Kong V, Deng Y, Chung P.
PMID: 42782851 [PubMed - indexed for MEDLINE]
Triple detection of the tumor proteins p63, Ki-67 and Alpha-methylacyl-CoA racemase in the pathological diagnosis of prostate cancer.
J Med Biochem
Niu M, Zhao D, He R, Qin L, Li Z, Zhang S, Chen L.
PMID: 42781326 [PubMed]
Articles 1 - 20 / 181678
Page 1 of 9084
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy